Ipamorelin is a selective secretagogue that increases pulse frequency while producing minimal cortisol and prolactin elevation, which distinguishes it from older secretagogues like GHRP-2 and GHRP-6
The top symptoms that improved included energy, pain, and mood
However, the potentially large target patient population, as well as the increased utilization and high drug costs, are a growing concern for many plan sponsors
As its predicted GLP-1 use will continue to rise in OSA patients, a common topic in discussions, according to Peters, is how GLP-1s might affect the use of other sleep apnea therapies, like CPAP, oral appliances, and hypoglossal nerve stimulation
Supplementation helps improve physical performance when combined with an
Serious complications, including allergic reactions or infections if administered incorrectly, are rare